203 related articles for article (PubMed ID: 31781935)
1. Alternative pathway of complement activation has a beneficial role against Chandipura virus infection.
Gupta P; Tripathy AS
Med Microbiol Immunol; 2020 Apr; 209(2):109-124. PubMed ID: 31781935
[TBL] [Abstract][Full Text] [Related]
2. Complement-Mediated Neutralization of a Potent Neurotropic Human Pathogen, Chandipura Virus, Is Dependent on C1q.
Kunnakkadan U; Nag J; Kumar NA; Mukesh RK; Suma SM; Johnson JB
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315998
[TBL] [Abstract][Full Text] [Related]
3. Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus.
Johnson JB; Capraro GA; Parks GD
Virology; 2008 Jun; 376(1):112-23. PubMed ID: 18440578
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.
Hook LM; Lubinski JM; Jiang M; Pangburn MK; Friedman HM
J Virol; 2006 Apr; 80(8):4038-46. PubMed ID: 16571820
[TBL] [Abstract][Full Text] [Related]
5. Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1.
Friedman HM; Wang L; Pangburn MK; Lambris JD; Lubinski J
J Immunol; 2000 Oct; 165(8):4528-36. PubMed ID: 11035093
[TBL] [Abstract][Full Text] [Related]
6. Role of cell surface vimentin in Chandipura virus replication in Neuro-2a cells.
Kavathekar VK; Dhanavade MJ; Sonawane KD; Balakrishnan A
Virus Res; 2020 Aug; 285():198014. PubMed ID: 32418904
[TBL] [Abstract][Full Text] [Related]
7. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
Leddy JP; Simons RL; Douglas RG
J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
[TBL] [Abstract][Full Text] [Related]
8. A peptide targeted against phosphoprotein and leader RNA interaction inhibits growth of Chandipura virus -- an emerging rhabdovirus.
Roy A; Chakraborty P; Polley S; Chattopadhyay D; Roy S
Antiviral Res; 2013 Nov; 100(2):346-55. PubMed ID: 24036128
[TBL] [Abstract][Full Text] [Related]
9. Ribavirin inhibits Chandipura virus replication in Vero cells.
Balakrishnan A; Mun AB
J Med Virol; 2020 Dec; 92(12):2969-2975. PubMed ID: 32543712
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
Nemerow GR; Jensen FC; Cooper NR
J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
[TBL] [Abstract][Full Text] [Related]
11. Chandipura Virus Utilizes the Prosurvival Function of RelA NF-κB for Its Propagation.
Bais SS; Ratra Y; Khan NA; Pandey R; Kushawaha PK; Tomar S; Medigeshi G; Singh A; Basak S
J Virol; 2019 Jul; 93(14):. PubMed ID: 31043529
[TBL] [Abstract][Full Text] [Related]
12. Monocytes and B cells support active replication of Chandipura virus.
Roy S; Pavitrakar D; Gunjikar R; Ayachit VM; Bondre VP; Sapkal GN
BMC Infect Dis; 2016 Sep; 16():487. PubMed ID: 27628855
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
Sturtevant JE; Balber AE
Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
[TBL] [Abstract][Full Text] [Related]
14. Interactions of human complement with virus particles containing the Nipah virus glycoproteins.
Johnson JB; Aguilar HC; Lee B; Parks GD
J Virol; 2011 Jun; 85(12):5940-8. PubMed ID: 21450814
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel rapid micro-neutralization ELISA for the detection of neutralizing antibodies against Chandipura virus.
Damle RG; Patil AA; Bhide VS; Pawar SD; Sapkal GN; Bondre VP
J Virol Methods; 2017 Feb; 240():1-6. PubMed ID: 27856212
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejection.
Spitzer R; Stitzel A; Florio L; Urmson J
Immunochemistry; 1976 May; 13(5):395-400. PubMed ID: 780264
[No Abstract] [Full Text] [Related]
17. Antiviral effect of Favipiravir against Chandipura virus in vitro and in vivo.
Pavitrakar DV; Bondre VP
J Med Virol; 2023 Jun; 95(6):e28840. PubMed ID: 37254846
[TBL] [Abstract][Full Text] [Related]
18. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes.
Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR
J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126
[TBL] [Abstract][Full Text] [Related]
19. Recombinant glycoprotein based vaccine for Chandipura virus infection.
Venkateswarlu CH; Arankalle VA
Vaccine; 2009 May; 27(21):2845-50. PubMed ID: 19428894
[TBL] [Abstract][Full Text] [Related]
20. Isolation of Chandipura virus (Vesiculovirus: Rhabdoviridae) from Sergentomyia species of sandflies from Nagpur, Maharashtra, India.
Sudeep AB; Bondre VP; Gurav YK; Gokhale MD; Sapkal GN; Mavale MS; George RP; Mishra AC
Indian J Med Res; 2014 May; 139(5):769-72. PubMed ID: 25027088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
